Literature DB >> 6153864

Sickle beta 0 thalassemia in Eastern Saudi Arabia.

M E Pembrey, R P Perrine, W G Wood, D J Weatherall.   

Abstract

The sickle cell (beta s) gene occurs at a high frequency in the oasis populations of Eastern Saudi Arabia. However, as compared with the disorder in Africans, sickle cell anemia runs an unusually benign clinical course in this populations; this has been attributed in part to the relatively high levels of fetal hemoglobin (Hb F) which characterize Saudi Arabians with this condition [1, 2]. As yet, there is no satisfactory explanation for this remarkable phenomenon. To learn more about the expression of the beta s gene in Eastern Saudi Arabia, we examined its interaction with beta 0 thalassemia. We found that remarkably high levels of Hb F in this population are not restricted to individuals with sickle cell anemia but also occur in compound heterozygotes for the beta s and beta 0 thalassemia (beta 0 thal) genes. Additionally, this study has characterized sickle cell-beta 0 thalassemia (S-beta 0 thal) in Eastern Saudi Arabia for the first time.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153864      PMCID: PMC1685932     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  A new form of hereditary persistence of fetal hemoglobin in blacks and its association with sickle cell trait.

Authors:  G Stamatoyannopoulos; W G Wood; T Papayannopoulou; P E Nute
Journal:  Blood       Date:  1975-11       Impact factor: 22.113

2.  Interaction of heterocellular hereditary persistence of foetal haemoglobin with beta thalassaemia and sickle cell anaemia.

Authors:  W G Wood; D J Weatherall; J B Clegg
Journal:  Nature       Date:  1976-11-18       Impact factor: 49.962

3.  Stimulation of fetal hemoglobin synthesis in bone marrow cultures from adult individuals.

Authors:  T H Papayannopoulou; M Brice; G Stamatoyannopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

4.  Haemoglobin Bart's in Saudi Arabia.

Authors:  M E Pembrey; D J Weatherall; J B Clegg; C Bunch; R P Perrine
Journal:  Br J Haematol       Date:  1975-02       Impact factor: 6.998

5.  Heterocellular hereditary persistence of fetal haemoglobin (heterocellular HPFH) and its interaction with beta thalassaemia.

Authors:  W G Wood; D J Weatherall; J B Clegg; T J Hamblin; J H Edwards; A M Barlow
Journal:  Br J Haematol       Date:  1977-08       Impact factor: 6.998

6.  The clinical features of sickle-cell- thalassaemia in Jamaica.

Authors:  G R Serjeant; M T Ashcroft; B E Serjeant; P F Milner
Journal:  Br J Haematol       Date:  1973-01       Impact factor: 6.998

7.  Reliable routine estimation of small amounts of foetal haemoglobin by alkali denaturation.

Authors:  M E Pembrey; P McWade; D J Weatherall
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

8.  F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F.

Authors:  W G Wood; G Stamatoyannopoulos; G Lim; P E Nute
Journal:  Blood       Date:  1975-11       Impact factor: 22.113

9.  The patterns of fetal haemoglobin production in leukaemia.

Authors:  B L Sheridan; D J Weatherall; J B Clegg; J Pritchard; W G Wood; S T Callender; I J Durrant; W R McWhirter; M Ali; J W Partridge; E N Thompson
Journal:  Br J Haematol       Date:  1976-04       Impact factor: 6.998

10.  Fetal erythropoiesis following bone marrow transplantation.

Authors:  B P Alter; J M Rappeport; T H Huisman; W A Schroeder; D G Nathan
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

View more
  9 in total

Review 1.  Regulation of human fetal hemoglobin: new players, new complexities.

Authors:  Arthur Bank
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

Review 2.  Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.

Authors:  Alawi H Habara; Elmutaz M Shaikho; Martin H Steinberg
Journal:  Am J Hematol       Date:  2017-08-17       Impact factor: 10.047

3.  Sickle cell cholangiopathy: an endoscopic retrograde cholangiopancreatography evaluation.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed Al-Salem
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

4.  Sickle cell disease in Saudi Arabs in early childhood.

Authors:  R P Perrine; P John; M Pembrey; S Perrine
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

5.  Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.

Authors:  Abdulrahman Alsultan; Mohammed K Alabdulaali; Paula J Griffin; Ahmed M Alsuliman; Hazem A Ghabbour; Paola Sebastiani; Waleed H Albuali; Amein K Al-Ali; David H K Chui; Martin H Steinberg
Journal:  Br J Haematol       Date:  2013-11-13       Impact factor: 6.998

6.  Molecular bases of beta-thalassemia in the Eastern Province of Saudi Arabia.

Authors:  Amein K Al-Ali; Suad Al-Ateeq; Burhan W Imamwerdi; Saleh Al-Sowayan; Mohammed Al-Madan; Fahad Al-Muhanna; Laila Bashaweri; Foad Qaw
Journal:  J Biomed Biotechnol       Date:  2005

Review 7.  Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf area.

Authors:  Mohamad H Qari; Yasser Wali; Muneer H Albagshi; Mohammad Alshahrani; Azzah Alzahrani; Ibrahim A Alhijji; Abdulkareem Almomen; Abdullah Aljefri; Hussain H Al Saeed; Shaker Abdullah; Ahmad Al Rustumani; Khoutir Mahour; Shaker A Mousa
Journal:  Orphanet J Rare Dis       Date:  2013-09-17       Impact factor: 4.123

8.  ERCP in Patients With Sickle Cell Disease: Diagnostic and Therapeutic Dilemmas.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed H Al-Salem
Journal:  Gastroenterology Res       Date:  2010-03-20

9.  Epidemiology of Thalassemia in Gulf Cooperation Council Countries: A Systematic Review.

Authors:  Amani Abu-Shaheen; Humariya Heena; Abdullah Nofal; Doaa A Abdelmoety; Abdulrahman Almatary; Mohammed Alsheef; Isamme AlFayyad
Journal:  Biomed Res Int       Date:  2020-10-28       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.